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Wide differences exist among primary isolates of HIV-1 in their sensitivity to antibody-mediated neutralization. While it is
well documented that even short-term tissue culture amplification of HIV-1 leads to a reduction in the genetic diversity of the
viral quasispecies seen in vivo, viral isolates, while relatively homogeneous, are generally not clonal. We investigated whether
the extent of genetic diversity within primary viral isolates correlates with their general susceptibility to neutralization. We
compared the number of V1V2 and V3-V5 envelope variants detectable within 16 primary isolates selected to represent the
extremes of the neutralization sensitive and resistant phenotypes. Using DNA heteroduplex tracking assays to estimate the
extent of genetic diversity in these two regions of the envelope locus, we found that these primary isolates were made up
of one to five distinguishable V1V2 and V3-V5 sequence variants. We found that higher levels of env genetic diversity did not
correlate with increased resistance to antibody neutralization. © 2000 Academic PressINTRODUCTION
Primary HIV-1 isolates used in antibody neutralization
experiments are typically derived by short-term coculture
of PBMC from an HIV-1-positive subject with activated
PBMC from an HIV-1-negative donor. The high levels of
resulting virus replication provide a culture supernatant
viral stock of sufficient titer to use in neutralization as-
says. Many, although not all, primary isolates are highly
resistant to antibody-mediated neutralization (Kostrikis et
al., 1996; Moore et al., 1995, 1996; Wrin et al., 1995; Wrin
and Nunberg, 1994). In contrast T-cell line adapted
(TCLA) HIV-1 strains, generated following multiple pas-
sages in permanent cell lines, are highly sensitive to
antibody-mediated neutralization (Spenlehauer et al.,
1998; Sullivan et al., 1995; Wrin et al., 1995). Long-term in
vitro replication in the absence of neutralizing antibodies
are thought to select for rapidly replicating TCLA viruses
with extreme sensitivity to neutralizing antibodies (Moore
and Ho, 1995; Sullivan et al., 1995).
Primary isolates exhibit wide variation in neutralization
sensitivity. Some primary isolates are highly resistant to
neutralization with most sera while others are readily
neutralized using identical sera (Kostrikis et al., 1996;
Moore et al., 1996). Since primary isolates are generated
in a similar fashion, such variation in neutralization sen-
sitivity cannot be ascribed to difference in selection pres-
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326sures occurring during in vitro amplification as occurs for
TCLA viruses. The observation that primary isolates with
different neutralization sensitivities can use either
CXCR4 or CCR5 indicated that coreceptor usage is not a
major determinant of their susceptibility to neutralizing
antibodies (LaCasse et al., 1998; Trkola et al., 1998).
To explain such widely different neutralization sensi-
tivity between primary isolates, we investigated another
variable property of HIV-1 isolates, their level of genetic
diversity. While the existence of molecular clone-derived
viruses with highly neutralization resistant phenotypes
clearly indicates that resistance can be found in genet-
ically homogeneous virus populations, the analysis of
primary isolates is complicated by the quasispecies na-
ture of such isolates. It has been extensively docu-
mented that the process of generating primary isolates
leads to a reduction in the genetic diversity of the viral
isolates relative to the proviral population in the input
PBMC (Delwart et al., 1994, 1997b; Kuiken et al., 1992;
Kusumi et al., 1992; Meyerhans et al., 1989). These re-
ports also showed that some (albeit low) degree of ge-
netic diversity still existed within primary viral isolates.
The frequent observation that even minor envelope se-
quence changes can drastically influence the properties
of molecular clone derived viruses (Fox et al., 1997;
McKeating et al., 1992; Mo et al., 1997; Moore et al., 1993;
Stamatatos and Cheng-Mayer, 1998; Sullivan et al., 1993;
Thali et al., 1994; Watkins et al., 1993, 1996; Yoshiyama et
al., 1994) suggested that distinct variants within isolates
may respond differently to neutralization with a given
serum. Therefore it remained possible that the larger the
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327EFFECTS OF GENETIC DIVERSITY ON NEUTRALIZATION SENSITIVITYnumber of envelope variants or genetic diversity within
an isolate, the greater the likelihood that the viral popu-
lation contained at least one variant resistant to neutral-
ization. According to this simple model, high genetic
diversity may correlate with resistance to antibody-me-
diated neutralization while a genetically homogeneous
isolate would be more sensitive. To test this hypothesis,
we estimated the number of envelope sequence variants
found within primary isolates and compared it to their
general neutralization properties. Direct sequencing of
env PCR products only yields the population consensus
sequence while subcloning/sequencing multiple plas-
mids does not readily identify minor variants. We there-
fore determined the quasispecies diversity of primary
isolates using heteroduplex tracking assays (HTA), a
nonsequencing approach able to detect low frequency
variants and compared it to the general neutralization
property of the same isolates.
RESULTS
We determined the level of genetic diversity at the
envelope V1V2 and V3-V5 regions of 16 primary viral
isolates. We chose for this purpose primary isolates for
which extensive neutralization data using a large number
of different sera were available. Reports by Moore et al.
(1996) and Kostrikis et al. (1996) were used as a basis for
T
Neutralizatio
Primary
isolate Subtype
Coreceptor
usageb
50% neutralization
Average Median
BR023 B ND 39.6 0
US716 B (NSI) 99.5 8
TH014 B (NSI) 72.3 128
MW101 C ND 164 256
UG001 D (SI) 128 64
UG005 D (NSI) 75.8 64
TH022 E (NSI) R5 76.5 128
TH009 E (NSI) 44.2 16
HT593 B (NSI) R5X4 39 0
US712 B (SI) 23.5 0
R020 B (NSI) R5 10 0
T594 B (SI) R5X4 0 0
W960 C (NSI) 0 0
G046 D (SI) X4 6.8 0
G024 D (ND) X4 2.3 0
H975 E (NSI) 0 0
a When the dilution endpoint was not reached (i.e. the highest dilutio
as assigned. When the lowest dilution (1:8) did not show any neu
eutralization data was derived from Kostrikis et al., (1996) and Moore
b Phenotypes in parentheses.selecting isolates, which were then classified as either
generally resistant or generally sensitive to neutraliza-tion using a panel of 16–21 sera from infected individu-
als. Isolates belonging to four HIV-1 group M subtypes
(B, C, D, and E) were selected. Sensitivity to neutraliza-
tion varied according to the particular serum tested and
the exact definition of neutralization. In Table 1, we show
(using values derived from reports from Kostrikis et al.,
1996 and Moore et al., 1996) the average and median
serum dilution of the 16–21 sera tested against each
isolate that resulted in a 50 and a 90% reduction in p24
output. Also shown is the average and median value of
the neutralization index. The neutralization index method
of measuring virus neutralization takes into account the
area under the neutralization curve bound by the lowest
and highest serum dilution measurement (Kostrikis et al.,
1996). Neutralization index values provide a composite
value of often irregular neutralization curves. A positive
neutralization index indicates neutralization while a neg-
ative value reflects enhancement of virus infectivity. Us-
ing the average and median values of these three neu-
tralization properties (50 and 90% reduction in p24 output
and neutralization index) to determine the general sus-
ceptibility of primary isolates to serum neutralization, we
selected primary isolates representing the extremes of
the neutralization-sensitive and neutralization-resistant
phenotypes and determined their quasispecies diversity.
The number of env sequence variants within the viral
itivity Data
Neutralization propertiesa
90% neutralization Neutralization index General
susceptibility
neutralizationverage Median Average Median
18.6 0 ND ND 1
70.5 0 ND ND 1
0.7 0 210 224 1
5.5 0 268 287 1
52.9 8 251 312 1
20.5 0 223 256 1
16.7 0 301 282 1
15.6 0 180 192 1
0 0 2237 137 2
5 0 2425 2394 2
0 0 18 4 2
0 0 22599 23129 2
0 0 235 245 2
0 0 214 232 2
0 0 2204 2124 2
0 0 2134 2160 2
28 still resulted in 50 or 90% neutralization), a neutralization titer of 256
on, a titer of 0 was assigned. ND indicates no data was available.
(1996).ABLE 1
n Sens
A
n of 1:1
tralizatiRNA populations of these primary isolates was deter-
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RNA was extracted and reversed transcribed before
nested PCR was used to separately amplify the V1V2 and
V3-V5 regions. A complementary, radiolabeled, clonal
single-stranded DNA probe was then annealed to the
nested PCR DNA products, and the resulting radiola-
beled DNA heteroduplexes were separated on a nonde-
naturing polyacrylamide gel (see Materials and Meth-
ods). The exact mobility of a DNA heteroduplex is influ-
enced by the size, sequence, and location of nucleotide
triplets insertions or deletions in the length polymorphic
V1, V2, V4, and V5 regions as well as by the exact number
and sequence of neighboring mismatched base pairs
(Delwart and Gordon, 1997). The number of HTA bands
therefore provides an estimate of the number of se-
quence variants present in the viral isolates. Because
some distinct variants may form heteroduplexes that
comigrate electrophoretically, the number of variants de-
tected by HTA represents a minimum estimate of the
extent of genetic diversity.
To ensure that the sampling of envelope variants
within viral populations was sufficient to correctly reflect
their level of diversity, duplicate-independent nPCR were
generated using separate aliquots of cDNA (Delwart and
Gordon, 1997; Delwart et al., 1997a). Only isolates that
gave reproducible HTA patterns in independent nPCRs
(confirming correct viral population sampling) were used.
Sixteen isolates gave reproducible HTA patterns and
were included in this analysis. A further four isolates
yielded discordant HTA results and were excluded from
further study. After scanning the HTA bands using a
PhosphorImager (Molecular Dynamics, Inc.), we deter-
mined that HTA bands making up as little as 2% of the
FIG. 1. Reproducible population sampling and genetic diversity of vir
from primary isolate cDNA were reannealed with radiolabeled single-
polyacrylamide gels. Single-stranded HTA probe alone (lanes 1) and pro
of the single-strand DNA and DNA homoduplex, respectively. The numb
shown to demonstrate reproducibility of population sampling. Dots aretotal signal could be reproducibly identified (data not
shown). The limit of detection for minor variants wastherefore $2% of the quasispecies. In Fig. 1, represen-
tative HTA patterns are shown to demonstrate the repro-
ducibility of the sampling in independent nPCRs and the
difference in the number of variants that can be identified
in different primary isolates.
The number of variants identified in V1V2 and V3-V5
were then compared to the general neutralization prop-
erty of the primary isolates ( 6 in Table 2). A t test found
o statistically significant correlation between the num-
er of variants in either V1V2, V3-V5 or both regions
ombined and the general (6) neutralization property of
he primary isolate. Correlation tests (two-tailed Pearson)
ere also made between the different neutralization des-
ispecies. Duplicate and triplicate independent nPCR products derived
d probes and DNA heteroduplexes were resolved on nondenaturing
nnealed to perfectly complementary PCR (lanes 2) indicate the location
istinct HTA bands is indicated below each duplicate or triplicate lanes
oned next to the HTA bands.
TABLE 2
Variants Compared to Neutralization Property of Primary Isolates
Primary
isolate
General
susceptibility
neutralization
Number of env variants
V1V2 V3–V5 V1V2 1 V3–V5
BR023 1 2 2 4
US716 1 2 1 3
TH014 1 3 2 5
MW101 1 1 1 2
UG001 1 1 1 2
UG005 1 2 1 3
TH022 1 2 3 5
TH009 1 2 1 3
HT593 2 2 2 4
US712 2 1 2 3
BR020 2 5 3 8
HT594 2 1 4 5
MW960 2 2 1 3
UG046 2 1 1 2
UG024 2 2 1 3al quas
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329EFFECTS OF GENETIC DIVERSITY ON NEUTRALIZATION SENSITIVITYignations and the number of sequence variants within
isolates. A total of 15 different correlation tests were
made: 50% neutralization averages, 50% neutralization
medians, 90% neutralization averages, neutralization in-
dex averages, and neutralization index medians were
compared to the number of variants in V1V2, V3-V5, and
V1V21V3-V5 combined. No statistically significant trend
was found in any of the 15 different correlation tests
except for a weak 20.6 correlation coefficient (P 5 0.02)
between the number of V3-V5 variants and both neutral-
ization index values. This correlation was lost if a single
data point (HT594 with the highest neutralization index
value) was removed from the analysis. The preponder-
ance of the analyses therefore showed no correlation
between the level of genetic diversity of primary isolates
and their propensity to resist serum neutralization.
DISCUSSION
While DNA clone-derived viruses have been exten-
sively used to map genetic determinants of neutralization
resistance to various regions of env (Cheng-Mayer et al.,
1999; McKeating et al., 1992; Reitter et al., 1998; Schon-
ing et al., 1996), the role of genetic diversity of uncloned
rimary viral isolates in their senitivity to neutralization
emained unexamined. In this study, we show that a
igher level of genetic diversity within primary isolates is
ot associated with a higher level of resistance to serum
eutralization. It therefore appears that factors other than
imply the level of genetic diversity in V1V2 and V3-V5
ccount for the wide range of sensitivity of primary HIV-1
solates to serum-mediated neutralization.
The absence of a clear correlation between genetic
iversity and resistance to neutralization, at least as
etected using neutralization assays based on 50 or 90%
eductions in p24 output, indicates that the distinct vari-
nts found within primary isolates posses similar neu-
ralization properties at least when tested using poly-
lonal sera. Nonetheless it remains possible that neu-
ralization-resistant variants present at frequencies
10% of the quasispecies would not be detected by a
eutralization assay based on a 90% reduction in p24
utput and that the use of more stringent neutralization
riterion might yet reveal a link between viral genetic
iversity and resistance to neutralization. Neutralization
ssays based on a reduction in the TCID50 of a primary
solate (determined following an extended infected cell
ncubation period to determine the viral end point titer)
ay be better able to detect the presence of low fre-
uency neutralization resistant variants.
In conclusion, readily measurable levels of genetic
iversity were found within primary isolates. High levels
f envelope quasispecies diversity were not associated
ith increased resistance to antibody-mediated neutral-
zation as measured by standard p24 reduction assays.MATERIALS AND METHODS
RT-nPCR. RNA was extracted and reverse transcribed
rom 0.2 ml of the primary isolate supernatants using a
reviously described method (Delwart et al., 1997a). Viral
RNA was reverse transcribed using a previously de-
scribed primer (Boom et al., 1990). For the V1V2 region,
the first-round PCR primers were ED5 and CG4 (GCTA-
GACTGCCATTTAACAG), and for the second nested PCR
round (G1GTAAAATTAACCCCACTCTG) and CG2 (TTC-
CATGTGTACATTGTACTGTGC) were used to amplify a
351-bp-long target sequence (on the HXB2 genome). For
the V3-V5 region, first-round primers were KK1 and ED12,
and for the second-round, ES7 and ES8 used to amplify
a target sequence 627-bp long (on the HXB2 genome)
(Delwart et al., 1993, 1997a).
DNA heteroduplex tracking assays (HTA). Duplicate,
independently derived, nPCR products derived from pri-
mary isolate cDNA were reannealed in an approximately
100:1 ratio with a 32P-radiolabeled, single-stranded DNA
strand derived (by PCR) from a plasmid containing an
envelope fragment of the same subtype as the primary
isolate under study (Delwart and Gordon, 1997; Delwart
et al., 1997a,b). HTA probes of the same subtype as the
quasispecies under study were used to maximize the
number of variants that could be resolved by this assay
since a probe from a different subtype would lead to
heteroduplexes of such reduced mobilities that discrim-
ination between closely related variants is reduced. After
reannealing the single-stranded HTA probe with the PCR
products from the primary isolates, the resulting radiola-
beled DNA heteroduplexes were resolved in a 5% non-
denaturing polyacrylamide gel and their electrophoretic
mobilities were determined using a Molecular Dynamic
PhosphorImager.
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